Search Results
India: Covaxin yet to get DCGI nod for kids | Covid 19 |Covid Vaccination | WION News | English News
Covaxin Gets DCGI Nod For Restricted Emergency Use In Children
Covaxin gets DCGI nod for 6-12 age group, Corbevax for 5-12-year-olds
DCGI gives nod to ‘Corbevax’ COVID vaccine for 5-12 age group
Covaxin Gets Approval For Emergency Use For Children Aged 12, Above | Breaking News
Coronavirus Vaccine News | DCGI Approves Phase 2 And 3 Trials Of Covaxin Of 2-18 Year-Old
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
Covaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs
Covid-19 Vaccine For Kids | Covaxin Gets Approval For Phase 2-3 Clinical Trials For 2-18 Age Group
DCGI approves phase 2, 3 trials of ‘Covaxin’ on 2 to 18 year-olds
India: DCGI approves Serum & Bharat Biotech vaccines for emergency use | Covaxin | Covishield
SII’s Covishield gets nod from DCGI’s expert panel; Covaxin yet to be given approval